Delivery Order SPE2DB20D3103-SPE2DB24FQ0S5

Award Date 8/28/24
Potential Completion Date 8/29/24
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,710.98 firm-fixed-price delivery order covers the supply of Velphoro 500 mg chewable tablets. The contract has a period of performance through March 21, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,822.01, is for the delivery of Velphoro 500 mg chewable tablets. This is a firm-fixed-price delivery order contract with an ultimate completion date of April 9, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,743.13, is a Delivery Order for the supply of Velphoro 500 mg chewable tablets. It is not a set-aside contract. The contract has an ultimate completion date of October 10, 2024. Amerisourcebergen holds several significant Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,807.52, is for the delivery of Velphoro 500 mg chewable tablets. The contract has an ultimate completion date of October 31, 2022 and is a firm-fixed-price delivery order. The contract was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,134.20 firm-fixed-price delivery order is for the supply of VELPHORO 500 MG CHEWABLE TAB 90S, a pharmaceutical product. The contract has an ultimate completion date of November 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,014.69 firm fixed-price delivery order is for the supply of VELPHORO 500 MG CHEWABLE TAB 90S, a specialty pharmaceutical product. The contract has an ultimate completion date of February 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of Velphoro 500 mg chewable tablets to the Defense Logistics Agency (DLA). The contract, valued at $20,084.57, is a firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Velphoro 500 mg chewable tablets. The contract has a ceiling value of $3,940.95 and a completion date of May 15, 2024. It is a firm fixed-price contract and was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of Velphoro 500 mg chewable tablets. The contract has a ceiling value of $6,581.47 and a completion date of July 23, 2024. It is a Firm Fixed Price Delivery Order with no set-aside requirements, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award, valued at $4,147.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Velphoro 500 mg chewable tablets, a medication used in the treatment of certain health conditions. The contract is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FQ0S5
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,529.90 firm fixed-price delivery order (SPE2DB24FQ0S5) is for the procurement of Velphoro 500 mg chewable tablets. The award is not designated under any set-aside program.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 9:53 AM